Negative regulation of the NLRP3 inflammasome by A20 protects against arthritis

Nature

Volumn 512, Issue 1, 2014, Pages 69-73

  Walle, Lieselotte Vande ^a,b   Van Opdenbosch, Nina ^a,b   Jacques, Peggy ^b   Fossoul, Amelie ^a,b   Verheugen, Eveline ^b   Vogel, Peter ^c   Beyaert, Rudi ^a,b   Elewaut, Dirk ^b   Kanneganti, Thirumala Devi ^c   Van Loo, Geert ^a,b   Lamkanfi, Mohamed ^a,b  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; APOPTOSIS REGULATORY PROTEINS; ARTHRITIS, RHEUMATOID; CALCIUM-BINDING PROTEINS; CARRIER PROTEINS; CASPASE 1; CYSTEINE ENDOPEPTIDASES; DISEASE MODELS, ANIMAL; FEMALE; INFLAMMASOMES; INTERLEUKIN-1; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MACROPHAGES; MALE; MICE; MICE, KNOCKOUT; NUCLEAR PROTEINS; PHENOTYPE; RECEPTORS, INTERLEUKIN-1; SIGNAL TRANSDUCTION;

EID: 84905562455     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature13322     Document Type: Article

References (26)

1. Burger, D., Dayer, J. M., Palmer, G. & Gabay, C. Is IL-1 a good therapeutic target in the treatment of arthritis? Best Pract. Res. Clin. Rheumatol. 20, 879-896 (2006).
2. Matmati, M. et al. A20 (TNFAIP3) deficiency in myeloid cells triggers erosive polyarthritis resembling rheumatoid arthritis. Nature Genet. 43, 908-912 (2011).
3. Lamkanfi, M. & Dixit, V. M. Inflammasomes and their roles in health and disease. Annu. Rev. Cell Dev. Biol. 28, 137-161 (2012).
4. Bauernfeind, F. G. et al. Cutting edge: NF-kB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation byregulating NLRP3 expression. J. Immunol. 183, 787-791 (2009).
5. Wertz, I. E. et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kB signalling. Nature 430, 694-699 (2004).
6. Vereecke, L., Beyaert, R. & vanLoo, G. Theubiquitin- editingenzymeA20(TNFAIP3) is a central regulatorof immunopathology. Trends Immunol. 30, 383-391 (2009).
7. Lee, E. G. et al. Failure to regulate TNF-induced NF-kB and cell death responses in A20-deficient mice. Science 289, 2350-2354 (2000).
8. Boone, D. L. et al. The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nature Immunol. 5, 1052-1060 (2004).
9. Fernandes-Alnemri, T. et al. Cutting edge: TLR signaling licenses IRAK1 for rapid activation of the NLRP3 inflammasome. J. Immunol. 191, 3995-3999 (2013).
10. Juliana, C. et al. Non-transcriptional priming and deubiquitination regulate NLRP3 inflammasome activation. J. Biol. Chem. 287, 36617-36622 (2012).
11. Lin, K. M. et al. IRAK-1 bypasses priming and directly links TLRs to rapid NLRP3 inflammasome activation. Proc. Natl Acad. Sci. USA 111, 775-780 (2014).
12. Schroder, K. et al. Acute lipopolysaccharide priming boosts inflammasome activationindependentlyofinflammasome sensor induction. Immunobiology 217, 1325-1329 (2012).
13. Ippagunta, S. K. et al. Inflammasome-independent role of apoptosis-associated speck-like protein containing aCARD (ASC) in Tcell primingiscritical for collagen-induced arthritis. J. Biol. Chem. 285, 12454-12462 (2010).
14. Kolly, L. et al. Inflammatory role of ASC in antigen-induced arthritis is independent of caspase-1, NALP-3, and IPAF. J. Immunol. 183, 4003-4012 (2009).
15. Consortium, W. T. C. C. Genome-wide association study of 14, 000 cases of seven common diseases and 3, 000 shared controls. Nature 447, 661-678 (2007).
16. Dieguez-Gonzalez, R. et al. Analysis of TNFAIP3, a feedback inhibitor of nuclear factor-kB and the neighbor intergenic 6q23 region in rheumatoid arthritis susceptibility. Arthritis Res. Ther. 11, R42 (2009).
17. Plenge, R. M. et al. Two independent alleles at 6q23 associated with risk of rheumatoid arthritis. Nature Genet. 39, 1477-1482 (2007).
18. Thomson, W. et al. Rheumatoid arthritis association at 6q23. Nature Genet. 39, 1431-1433 (2007).
19. Ben Hamad, M. et al. Association studyof CARD8 (p. C10X) and NLRP3 (p. Q705K) variants with rheumatoid arthritis in French and Tunisian populations. Int. J. Immunogenet. 39, 131-136 (2012).
20. Kastbom, A. et al. Genetic variation in proteins of the cryopyrin inflammasome influences susceptibility and severity of rheumatoid arthritis (the Swedish TIRA project). Rheumatology (Oxford) 47, 415-417 (2008).
21. Mathews, R. J. et al. Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response to anti-TNF treatment. Ann. Rheum. Dis. 73, 1202-1210 (2014).
22. Mariathasan, S. et al. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440, 228-232 (2006).
23. Schott, W. H. et al. Caspase-1isnot requiredfor type1diabetesinthe NOD mouse. Diabetes 53, 99-104 (2004).
24. Glaccum, M. B. et al. Phenotypic and functional characterization of mice that lack the type I receptor for IL-1. J. Immunol. 159, 3364-3371 (1997).
25. Burke, J. R. et al. BMS-345541 is a highly selective inhibitor of I kappa B kinase that binds at an allosteric site of the enzyme and blocks NF-kappa B-dependent transcription in mice. J. Biol. Chem. 278, 1450-1456 (2003).
26. Podolin, P. L. et al. Attenuation of murine collagen-induced arthritis by a novel, potent, selective small molecule inhibitor of IkB kinase 2, TPCA-1 (2-[(aminocarbonyl)amino]-5-(4-fluorophenyl)-3-thiophenecarboxamide), occurs via reduction of proinflammatory cytokines and antigen-induced T cell proliferation. J. Pharmacol. Exp. Ther. 312, 373-381 (2005).